About this journal

Aims and scope

Drug, Healthcare and Patient Safety is an international, peer reviewed, open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treatment, drug therapy and surgery.

The journal is characterized by the rapid reporting of reviews, original research, clinical, epidemiological and post-marketing surveillance studies, risk management, health literacy and educational programs across all areas of healthcare delivery. Also, guidelines on data requirements to assure acceptable safety levels in license applications, post marketing protocols on monitoring safety, on managing associated morbidity and mortality are key topics. Adverse reaction case reports, animal and in vitro toxicity studies are also welcome. Balancing risk, effectiveness, patient satisfaction and quality of life and the development and testing of new interventions to optimize clinical outcomes in disease management are major areas of interest for the journal.

Drug, Healthcare and Patient Safety will no longer consider meta-analyses for publication.

Journal metrics

Usage

  • 41K annual downloads/views

Citation metrics

  • 2.2 (2023) Impact Factor
  • Q2 Impact Factor Best Quartile
  • 2.2 (2023) 5 year IF
  • 4.1 (2023) CiteScore (Scopus)
  • Q2 CiteScore Best Quartile
  • 1.145 (2023) SNIP
  • 0.571 (2023) SJR

Editorial board

Editor-in-Chief:

Dr Rajender R Aparasu, Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, United States

Associate Editors-in-Chief:

Professor Siew Siang Chua, School of Pharmacy, Taylor's University, Malaysia

Dr Hemalkumar B Mehta, Department of Epidemiology, Johns Hopkins University, United States

Editorial Board:

Dr Lise Aagaard, The Danish Council on Ethics, National Committee on Health Research Ethics, and Medical Research Ethics Committee, Denmark

Dr Syed Imran Ahmed, School of Pharmacy, College of Science, University of Lincoln, United Kingdom

Professor Chul Ahn, Clinical Sciences, UT Southwestern Medical Center, United States

Dr Bontha Babu, Socio-Behavioural & Health Systems Research, Indian Council of Medical Research, India

Professor Charles Bennett, Department of Clinical Pharmacy and Outcomes Sciences, South Carolina College of Pharmacy, United States

Dr Jongwha Chang, Department of Pharmaceutical Sciences, Irma Lerma Rangel School of Pharmacy, Texas A&M University, College Station, TX, United States

Professor Giorgio Lorenzo Colombo, Deptartment of Drug Sciences, University of Pavia, Italy

Dr Robin Jacobs, College of Osteopathic Medicine, Nova Southeastern University, United States

Dr Gerald Klein, Clinical Research, Medsurgpi LLC, Adjunct Professor of Pharmacology and Toxicology Brody School of Medicine at East Carolina University, United States

Dr Peter Koulen, Ophthalmology, University of Missouri Kansas City, School of Medicine, United States

Professor Peter Martin, Psychiatry and Pharmacology, Vanderbilt Psychiatric Hospital, Vanderbilt University School of Medicine, United States

Professor Raffaele Serra, Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Italy

Dr Bach Tran, Department of Health Economics, Hanoi Medical University, Vietnam

Prof. Dr. Vladimir Trkulja, Department of Pharmacology, Zagreb University School of Medicine, Croatia

Professor Chiara Verbano, Department of Management and Engineering, University of Padova, Italy

Professor Karen Wagner, Psychiatry & Behavioral Sciences, The University of Texas Medical Branch, United States

Professor John Zaia, Centre for Gene Therapy, City of Hope, United States

Abstracting and indexing

Drug, Healthcare and Patient Safety is indexed/tracked/covered by the following services:

Directory of Open Access Journals (DOAJ)

EMBASE (Elsevier)

Pubmed (NLM)

PubMed Central Selective Deposit Medicine & Health (NLM)

Scopus (Elsevier)

Open access

Drug, Healthcare and Patient Safety is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.

Use our APC finder to calculate your article publishing charge

Ready to submit?

Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window) Instructions for authors